Editorial commentary: Single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 694-696

  Dondorp, Arjen M ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRIMAQUINE;

ADD ON THERAPY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL THERAPY; COMBINATION CHEMOTHERAPY; DRUG TOLERABILITY; GAMETOCYTE; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INTRAVASCULAR HEMOLYSIS; MALARIA FALCIPARUM; NOTE; POINT OF CARE TESTING; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE;

EID: 84873615253     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis962     Document Type: Note

References (11)

1. Fairhurst RM, Nayyar GM, Breman JG, et al. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg 2012; 87:231-41.
2. Maude RJ, Pontavornpinyo W, Saralamba S, et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 2009; 8:31.
3. Sutanto I, Suprijanto S, Kosasih A, et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South Sumatra, Western Indonesia: an open-label, randomized controlled trial [published online ahead of print 21 November 2012]. Clin Infect Dis 2013; 56:685-93.
4. Matsuoka H, Ishii A, Panjaitan W, Sudiranto R. Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia. Southeast Asian J Trop Med Public Health 1986; 17:530-6.
5. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371:64-74.
6. World Health Organization Evidence Review Group. The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Available at: http://www. who.int/malaria/mpac/sep2012/primaquine-single-dose- pf-erg-meeting-report-aug2012. pdf. Accessed 1 November 2012.
7. Mackerras MJ, Ercole QN. Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1949; 42:455-63.
8. White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 2012. In press.
9. World Health Organization. Updated WHO policy recommendation (October 2012). Single dose primaquine as a gametocytocide in Plasmodium falciparum malaria. Available at: http://www.who.int/malaria/pq-updated-policy- recommendation-en-102012.pdf. Accessed 1 November 2012.
10. Lawpoolsri S, Klein EY, Singhasivanon P, et al. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J 2009; 8:159.
11. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an openlabel randomised trial. Lancet Infect Dis 2010; 10:673-81.